ecancer

Lecture: Clinical Perspectives: How far are we from personalising treatment for prostate cancer patients?

Dr Paul de Souza - University of Western Sydney, New South Wales, Australia

12 May 2014

Debate: Will chemotherapy continue to be standard treatment for symptomatic mCRPC in the era of novel agents? (against)

Dr Kurt Miller - Benjamin Franklin Medical Center, Berlin, Germany

12 May 2014

Lecture: Future strategies and targets for prostate cancer

Dr Kurt Miller - Benjamin Franklin Medical Center Berlin, Germany

12 May 2014

Surgical strategies available for renal cell carcinoma with inferior vena cava invasion

Prof Christopher G. Wood - The University of Texas MD Anderson Cancer Center, Houston, USA

6 May 2014

Use of robotics in kidney cancer surgery

Dr Christophe Vaessen - Groupe Hospitalier Pitié-Salpêtrière, Paris, France

6 May 2014

Work and history of the Kidney Cancer Association

Carrie Konosky - Vice President of Development & Public Affairs, Kidney Cancer Association, Chicago, USA

6 May 2014

Intratumour heterogeneity in renal and lung cancer

Prof Charles Swanton - CRUK London Research Institute and UCL, London, UK

6 May 2014

Kidney cancer treatment ten years from now

Prof Martin Gore - The Royal Marsden Hospital, London, UK

6 May 2014

Role of AORTIC in dealing with rising cancer rates in Africa

North American Vice president of AORTIC

1 May 2014

Biomarker development for ipilimumab and prostate GVAX treatment

Prof Tanja D. de Gruijl - VU University Medical Centre, Amsterdam, The Netherlands

26 Mar 2014

The 1st Immunotherapy of Cancer Conference (ITOC)

Prof Heinz Zwierina - Innsbruck Medical University, Innsbruck, Austria

25 Mar 2014

mRNA-based cancer vaccines

Dr Karl-Josef Kallen - Principal Scientific Fellow, CureVac Gmbh

24 Mar 2014

More from ecancer